# Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis

> **NCT02613884** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins All Children's Hospital** · enrollment: 26 (actual)

## Conditions studied

- Vitamin D Deficiency

## Interventions

- **DRUG:** Treatment

## Key facts

- **NCT ID:** NCT02613884
- **Lead sponsor:** Johns Hopkins All Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-11-25
- **Final completion:** 2019-11-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02613884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02613884, "Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02613884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*